3/17/26 17:37 | 3/14/26 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 0 | 0.00 | 0 | 17 | | 13 | D | | | | | | | | | | | | | | |
3/17/26 17:37 | 3/16/26 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -476 | 48.26 | 0 | -10 | -43 | 13 | D | | | | | | | | | | | | | | |
1/26/26 17:35 | 1/22/26 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 1,579 | 45.15 | 0 | 35 | | 7 | D | | | | | | | | | | | | | | |
1/26/26 17:35 | 1/22/26 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -2,105 | 60.19 | 0 | -35 | -84 | 7 | D | | | | | | | | | | | | | | |
1/8/26 17:35 | 1/6/26 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 1,336 | 44.97 | 0 | 30 | | 7 | D | | | | | | | | | | | | | | |
1/8/26 17:35 | 1/6/26 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -1,787 | 60.16 | 0 | -30 | -81 | 7 | D | | | | | | | | | | | | | | |
12/23/25 17:33 | 12/22/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S | -560 | 55.95 | 0 | -10 | -60 | 7 | D | | | | | | | | | | | | | | |
3/24/25 17:35 | 3/20/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 0 | 0.00 | 0 | 6 | 59 | 17 | D | | | | | | | | | | | | | | |
3/24/25 17:35 | 3/21/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -91 | 41.23 | 0 | -2 | -12 | 17 | D | | | | | | | | | | | | | | |
3/18/25 17:35 | 3/14/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 0 | 0.00 | 0 | 10 | 368 | 13 | D | | | | | | | | | | | | | | |
3/18/25 17:35 | 3/17/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -157 | 41.80 | 0 | -4 | -23 | 13 | D | | | | | | | | | | | | | | |
3/18/24 17:45 | 3/14/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 0 | 0.00 | 0 | 10 | | 6 | D | | | | | | | | | | | | | | |
3/18/24 17:45 | 3/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -256 | 72.69 | 0 | -4 | -35 | 6 | D | | | | | | | | | | | | | | |